SCHEMBL853964

SCHEMBL853964

CCCCCNc1nc(C)c(Cc2ccc(OCCCN3CCOCC3)cc2OC)c(N)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 14/20 0.49
ALDH1A1 P00352 3/20 0.45
MAPK1 P28482 2/20 0.45
CYP1A2 P05177 1/20 0.45
CHRM2 P08172 1/20 0.45
CHRM1 P11229 1/20 0.45
HTR2A P28223 1/20 0.45
SCN1A P35498 1/20 0.45
HTR2B P41595 1/20 0.45
KCNH2 Q12809 1/20 0.45
SCN2A Q99250 1/20 0.45
SIGMAR1 Q99720 1/20 0.45
SCN3A Q9NY46 1/20 0.45
HRH3 Q9Y5N1 1/20 0.45
USP2 O75604 1/20 0.45
LMNA P02545 1/20 0.45
TLR8 Q9NR97 2/20 0.43
POLB P06746 1/20 0.43
MAPT P10636 1/20 0.43
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL861166 0.93 TLR7 (0.48) TLR7HTR2ATLR8
SCHEMBL3696827 0.88 TLR7 (0.64) TLR7TLR8
SCHEMBL853744 0.83 TLR7 (0.46) TLR7POLBMAPT
SCHEMBL3704566 0.80 TLR7 (0.63) TLR7TLR8
SCHEMBL861355 0.79 TLR7 (0.56) TLR7HRH3TLR8
SCHEMBL19056665 0.79 TLR8 (0.48) TLR7HRH3TLR8
SCHEMBL861830 0.78 TLR7 (0.60) TLR7HRH3TLR8
SCHEMBL853783 0.76 TLR7 (0.45) TLR7USP2TLR8MAPTTSHR
SCHEMBL6125956 0.76 TLR8 (0.57) TLR7TLR8
SCHEMBL6125875 0.76 TLR8 (0.56) TLR7TLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2432768-A1 NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER AND FURTHER DISEASES AstraZeneca AB (SE) 2012-03-28 EP disclosed
WO-2010133885-A1 NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER AND FURTHER DISEASES ASTRAZENECA AB (SE) 2010-11-25 WO disclosed